Regencell Bioscience Holdings Ltd
(RGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2001 | |
| Sales | 556,900 |
| Cost of Goods | 231,000 |
| Gross Profit | 325,900 |
| Operating Expenses | 291,800 |
| Operating Income | 34,100 |
| Interest Expense | 21,400 |
| Other Income | -4,200 |
| Pre-tax Income | 8,500 |
| Income Tax | 3,600 |
| Net Income Continuous | 4,900 |
| Net Income | $4,900 |
| EPS Basic Total Ops | 0.30 |
| EPS Basic Continuous Ops | 0.30 |
| EPS Diluted Total Ops | 0.28 |
| EPS Diluted Continuous Ops | 0.28 |
| EBITDA(a) | $76,700 |